Hemophilia A Research Program (HARP) Education/ LinkedIn
Jul 22, 2026, 09:46
Clinical Trial Recruitment for the HARP Mother–Baby Study – HARP
Hemophilia A Research Program (HARP) Education shared a post on LinkedIn:
“The HARP mother-baby study in hemophilia is recruiting! Please help us get the word out!
Interested pregnant moms can go to HARP.
Providers can directly refer at: [email protected]
Flyers can also be downloaded at HARP Resources.
Hemophilia A Research Program (HARP) is looking to reach pregnant mothers anywhere in the U.S. Eligible moms have a genotype that causes hemophilia A (sometimes known as ‘carriers’) and a baby potentially at-risk for severe hemophilia A.
HARP is studying hemophilia bleeding risk in pregnancy and the causes of inhibitor formation in early childhood. To learn more visit HARP and Clinical Trials.”
Stay updated with Hemostasis Today.
-
Sep 19, 2026, 17:24Jan Shawqi Goran: Understanding Beta Thalassemia Before Marriage Testing
-
Sep 19, 2026, 14:17Abdul Mannan: What Exactly Is a Platelet?
-
Sep 19, 2026, 13:39Keisuke Goda: Decoding Platelet Phenotypes in COVID-19 With Optofluidic Imaging
-
Sep 19, 2026, 13:30Targeted Thrombolysis Beyond tPA
-
Sep 19, 2026, 13:21Paul Armstrong: From Summer Studentship to Young Researcher
-
Sep 19, 2026, 13:06Rabiya Masood: Breaking the Cycle of Thalassemia Through Screening
-
Sep 19, 2026, 10:52Consuela A. Albright: The Critical Role of Black Blood Donors in Sickle Cell Treatment
-
Sep 19, 2026, 10:47Amber Yates: Inside Agios’ Partnership with the Sickle Cell Community
-
Sep 19, 2026, 10:46Anton Farkas: Mechanical Thrombectomy for Acute PE in Early Pregnancy